CryoPort (NASDAQ:CYRX) Lowered to “Sell” Rating by Wall Street Zen

Wall Street Zen lowered shares of CryoPort (NASDAQ:CYRX) from a hold rating to a sell rating in a research report released on Saturday morning.

CYRX has been the subject of a number of other reports. Needham & Company LLC increased their price objective on CryoPort from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Wednesday. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of CryoPort in a research note on Monday, December 29th. Eight analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $12.94.

CryoPort Trading Down 3.2%

CryoPort stock opened at $8.09 on Friday. The company has a quick ratio of 15.01, a current ratio of 15.77 and a debt-to-equity ratio of 0.40. The firm has a 50-day moving average price of $9.43 and a two-hundred day moving average price of $9.39. The firm has a market capitalization of $405.07 million, a price-to-earnings ratio of 6.13 and a beta of 1.69. CryoPort has a 52-week low of $4.63 and a 52-week high of $11.45.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.02). The firm had revenue of $45.45 million during the quarter, compared to analyst estimates of $42.92 million. CryoPort had a net margin of 42.35% and a negative return on equity of 8.33%. Sell-side analysts expect that CryoPort will post -0.99 earnings per share for the current year.

Insider Activity at CryoPort

In related news, Director Ramkumar Mandalam sold 11,570 shares of the business’s stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $9.99, for a total transaction of $115,584.30. Following the sale, the director owned 80,758 shares of the company’s stock, valued at $806,772.42. The trade was a 12.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 10.00% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On CryoPort

Several hedge funds have recently modified their holdings of the company. Mak Capital One LLC bought a new stake in shares of CryoPort in the 3rd quarter worth $7,756,000. UBS Group AG boosted its stake in CryoPort by 112.7% during the third quarter. UBS Group AG now owns 1,331,521 shares of the company’s stock valued at $12,623,000 after buying an additional 705,649 shares in the last quarter. Millennium Management LLC grew its holdings in CryoPort by 23.8% during the fourth quarter. Millennium Management LLC now owns 3,244,802 shares of the company’s stock worth $31,150,000 after acquiring an additional 623,896 shares during the period. Kennedy Capital Management LLC bought a new stake in CryoPort in the second quarter worth about $4,084,000. Finally, Assenagon Asset Management S.A. raised its position in CryoPort by 37.4% in the third quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company’s stock worth $14,208,000 after acquiring an additional 408,263 shares in the last quarter. 92.90% of the stock is currently owned by institutional investors and hedge funds.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.